Open AccessPotential of lacto-N-biose I as a prebiotic for infant health: A review
Author(s) -
Warsono El Kiyat,
Santi Dwi Astuti,
Slamet Budijanto,
Elvira Syamsir
Publication year - 2021
Publication title -
communications in science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.136
H-Index - 5
eISSN - 2502-9266
pISSN - 2502-9258
DOI - 10.21924/cst.6.1.2021.277
Subject(s) - prebiotic , ingredient , infant formula , oligosaccharide , food science , human health , food products , biology , medicine , biochemistry , environmental health
Prebiotic is one alternative in the prevention of disease in infants. Generally, it is available as oligosaccharide which may occur naturally, but can also be added as a dietary supplement for food, beverage or formula. Lacto-N-biose I (LNB), a kind of prebiotic has not been widely examined in regard to its activities as a bifidogenic factor. Naturally, it is available in a compound form in human milk oligosaccharide (HMO) as the main constituent of human milk rather than fat and protein. HMOs also have prebiotic activity in the body and play an important role in providing nutrition for the infant health. LNB is potential to be used in food ingredient, especially infant food formula regarding the prebiotic effect and it could be enzymatically synthesized using enzymes involved in the LNB biosynthesis pathway by microorganisms.